Home/Filings/4/0000950170-25-004929
4//SEC Filing

WHITMORE R JANET 4

Accession 0000950170-25-004929

CIK 0000883107other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 5:35 PM ET

Size

13.3 KB

Accession

0000950170-25-004929

Insider Transaction Report

Form 4
Period: 2024-12-31
Transactions
  • Award

    Common Stock (Right to Buy)

    2024-12-31$2.44/sh+12,000$29,28012,000 total
    Exercise: $2.44From: 2025-12-31Exp: 2031-12-31Common Stock (12,000 underlying)
Holdings
  • Common Stock (right to purchase)

    Exercise: $4.17From: 2022-12-28Exp: 2028-12-28Common Stock (20,000 underlying)
    20,000
  • Common Stock

    2,049,142
  • Deferred Common Stock

    Common Stock (20,030 underlying)
    20,030
  • Common Stock (right to purchase)

    Exercise: $1.85From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.17From: 2023-12-20Exp: 2029-12-20Common Stock (13,334 underlying)
    13,334
  • Common Stock (right to purchase)

    Exercise: $0.61From: 2024-12-27Exp: 2030-12-27Common Stock (12,600 underlying)
    12,600
Footnotes (5)
  • [F1]Each share of deferred common stock represents the right to receive one share of common stock.
  • [F2]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
  • [F3]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
  • [F4]The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85.
  • [F5]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Documents

1 file

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

Entity typeother

Related Parties

1
  • filerCIK 0001173970

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:35 PM ET
Size
13.3 KB